NA
IDXX icon

Navellier & Associates’s Idexx Laboratories IDXX Stock Holding History

Navellier & Associates’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$335K Sell
596
-7,199
-92% -$4.62M 0.03% 271
2025
Q4 		$5.27M Buy
+7,795
New +$5.31M 0.59% 42
2024
Q2 		– Sell
-373
Closed -$201K – 353
2024
Q1 		$201K Hold
373
– – 0.02% 327
2023
Q4 		$207K Buy
+373
New +$175K 0.03% 305
2022
Q2 		– Sell
-1,245
Closed -$681K – 302
2022
Q1 		$681K Sell
1,245
-17,688
-93% -$9.3M 0.12% 155
2021
Q4 		$12.5M Buy
18,933
+2,032
+12% +$1.28M 1.81% 6
2021
Q3 		$10.5M Sell
16,901
-7
-0% -$4.7K 1.58% 8
2021
Q2 		$10.7M Buy
16,908
+4
+0% +$2.21K 1.61% 7
2021
Q1 		$8.27M Sell
16,904
-353
-2% -$177K 1.49% 8
2020
Q4 		$8.63M Buy
17,257
+16,480
+2,121% +$7.37M 1.56% 10
2020
Q3 		$305K Sell
777
-600
-44% -$222K 0.07% 184
2020
Q2 		$455K Sell
1,377
-89
-6% -$25.8K 0.11% 141
2020
Q1 		$355K Buy
1,466
+63
+4% +$16.4K 0.08% 162
2019
Q4 		$366K Sell
1,403
-109
-7% -$28.7K 0.06% 218
2019
Q3 		$411K Buy
1,512
+12
+0.8% +$3.34K 0.07% 194
2019
Q2 		$413K Sell
1,500
-11,968
-89% -$2.95M 0.06% 195
2019
Q1 		$3.01M Sell
13,468
-935
-6% -$193K 0.47% 59
2018
Q4 		$2.68M Sell
14,403
-1,764
-11% -$362K 0.46% 51
2018
Q3 		$4.04M Buy
16,167
+130
+0.8% +$31.6K 0.52% 52
2018
Q2 		$3.5M Buy
16,037
+135
+0.8% +$27.8K 0.49% 53
2018
Q1 		$3.04M Sell
15,902
-7,443
-32% -$1.37M 0.46% 60
2017
Q4 		$3.65M Sell
23,345
-38,206
-62% -$6.01M 0.68% 45
2017
Q3 		$9.57M Sell
61,551
-114
-0.2% -$18K 1.86% 11
2017
Q2 		$9.95M Sell
61,665
-11,246
-15% -$1.83M 1.49% 12
2017
Q1 		$11.3M Sell
72,911
-8,807
-11% -$1.21M 1.64% 10
2016
Q4 		$9.58M Buy
81,718
+40,022
+96% +$4.57M 1.58% 6
2016
Q3 		$4.7M Buy
+41,696
New +$4.39M 0.67% 53

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Navellier & Associates's IDXX Position: Q1 2026 in Review

Navellier & Associates reduced its Idexx Laboratories (IDXX) stake by 92% in Q1 2026, selling an estimated $4.62M and leaving 596 shares worth $335K. The position accounts for 0.03% of the portfolio, ranked #271.

Navellier & Associates first reported a position in IDXX in Q3 2016 and has held it in 27 quarters since. The position peaked at $12.5M in Q4 2021. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Navellier & Associates held 596 shares of Idexx Laboratories worth $335K as of Q1 2026.
  • Navellier & Associates sold 7,199 Idexx Laboratories shares in Q1 2026, an estimated $4.62M.
  • Idexx Laboratories made up 0.03% of Navellier & Associates's portfolio in Q1 2026, its #271 holding.
  • Navellier & Associates first reported a position in Idexx Laboratories in Q3 2016 and has held it in 27 quarters since.
  • Navellier & Associates's Idexx Laboratories position peaked at $12.5M in Q4 2021.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Navellier & Associates's 13F filing for Q1 2026, filed 7 May 2026.